Global /Australia /Healthcare /Drug Manufacturers - Specialty & Generic /BP8
chevron_leftBack
BPH Global Ltd. logo

BPH Global Ltd.

BP8
ASX: BP8 Delayed
0.0020AUD 0%
0.0014 USD
As of 7 June 2026, BPH Global Ltd. has a market cap of $3.36M USD, ranking #45805 globally and #1686 in Australia. It ranks #4056 in the Healthcare sector, and #295 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
45805
Country Rank
1686
Sector Rank
4056
Industry Rank
295
Key Stats
Market Cap
$3.36MUSD
4.71M AUD
Enterprise Value
$3.29MUSD
4.67M AUD
Revenue (TTM)
$1.23MUSD
1.73M AUD
EBITDA (TTM)
-$1.41MUSD
-2.0M AUD
Net Income (TTM)
-$1.52MUSD
-2.13M AUD
EBITDA Margin
-116%
Profit Margin
-123%
PS Ratio
2.7
PB Ratio
-5.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Matthew Leonard open_in_new
Employees
31
Founded
1984
Website
bphglobal.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 0% 0% 0% 0% -33%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
BP8
BPH Global Ltd
ISIN: AU0000284366
Shares Out.:
2.353B1
TV:
SA:
YF:
GF:
BA:
BP8
MS:
0.0020 AUD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About BPH Global Ltd.

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. BPH Global Ltd was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. The company was incorporated in 1984 and is headquartered in Melbourne, Australia.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Australia)
Name
Market Cap diff.
PE
$1.11B
1.55B AUD
33K%
52.7
$123.03M
172.39M AUD
4K%
-
$114.37M
160.26M AUD
3K%
18.1
$100.03M
140.17M AUD
3K%
14.1
$56.42M
79.06M AUD
2K%
-
BNIGF
$49.41M
1K%
-
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
1M%
24.2
$29.56B
880K%
-
$15.86B
107.34B CNY
472K%
16.0
CIPLA
$11.12B
1.06T INR
331K%
23.4
LUPIN
$11.0B
1.05T INR
327K%
22.7
$9.1B
61.6B CNY
271K%
80.6
chevron_leftBack